- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01286597
The Effects of Lactose Intolerance on Gastrointestinal Function and Symptoms in a Chinese Population
Lactose is a carbohydrate found in milk,and Lactase Deficiency (LD) is a condition in which the small intestine cannot digest this carbohydrate due to absent or insufficient amounts of lactase.Individuals with LD may be intolerant of lactose in the diet and experience abdominal cramps, bloating and diarrhea; however the response is variable.Some tolerate moderate amounts of lactose without adverse effect,whereas others experience severe symptoms in response to even small doses. These problems may be representative of wider issues regarding individual tolerance to diet containing ubiquitous poorly absorbed, fermentable carbohydrates (such as: fructose, fructans)and be relevant to symptom generated in patients with diarrhea predominant irritable bowel syndrome (D-IBS).
This project will investigate the effects of diet,lifestyle stress and psychiatric dietary on the development of functional gastrointestinal symptoms. Lactose will be used to assess tolerance to dietary challenge, a test that is particularly relevant in a Chinese population with a high prevalence of lactase deficiency.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study #1: Questionnaire study in general Chinese population (n=2000).
Study #2: Physiologic study in patients attending gastroenterology clinic (n=600) including in subgroups assessment of genetic factors,tolerance to lactose challenge and assessment of visceral sensitivity.
Study #3: Assessment of appropriate dosage of lactose hydrogen breath test in a population with high-prevalence of lactase deficiency.
Study #4: Impact of a determined dietary intervention on abdominal symptoms compatible with D-IBS.
study #5: The association of visceral sensitivity induced by LI with mucosal immune activation and psychological factors in D-IBS patients
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Zhejiang
-
Hangzhou, Zhejiang, China, 310016
- Recruiting
- Sir Run Run Shaw Hospital , College of Medicine, Zhejiang University, China
-
Contact:
- Ning Dai, MD
- Phone Number: 0086-13867457664
- Email: dainingcn@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Aged at least 16 years old and not more than 75 years old.
- Ability to communicate with the investigator, complete study questionnaires (with help of investigator) and provide informed consent.
Exclusion Criteria:
- Progressive, severe disease requiring active medical management (e.g. advanced cardiac, liver, renal or neurological disease, advanced cancer)
- History of significant gastrointestinal pathology (other than gastro-oesophageal reflux disease and functional bowel diseases)
- History of gastro-intestinal surgery (except appendicectomy, cholecystectomy, hernia repair).
- Evidence of active drug or alcohol abuse
Study Plan
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: dietary
|
restrict intake of lactose
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
To assess the effects of lactose intolerance on gastrointestinal function and symptoms
Time Frame: Three years
|
Three years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
To measure the intake of dietary lactose in the adult general population and in patients with IBS
Time Frame: three years
|
three years
|
|
To assess genetic factors, tolerance to lactose challenge and visceral sensitivity.
Time Frame: three years
|
three years
|
|
To assess appropriate dosage of lactose hydrogen breath test
Time Frame: two years
|
two years
|
|
To determine the impact of a determined dietary intervention on abdominal symptoms compatible with D-IBS.
Time Frame: three years
|
three years
|
|
To explore the association of visceral sensitivity induced by LI with mucosal immune activation and psychological factors in D-IBS patients
Time Frame: two years
|
two years
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Chair: Ning DAI, MD, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, China
Publications and helpful links
General Publications
- Yang JF, Fox M, Chu H, Zheng X, Long YQ, Pohl D, Fried M, Dai N. Four-sample lactose hydrogen breath test for diagnosis of lactose malabsorption in irritable bowel syndrome patients with diarrhea. World J Gastroenterol. 2015 Jun 28;21(24):7563-70. doi: 10.3748/wjg.v21.i24.7563.
- Yang J, Fox M, Cong Y, Chu H, Zheng X, Long Y, Fried M, Dai N. Lactose intolerance in irritable bowel syndrome patients with diarrhoea: the roles of anxiety, activation of the innate mucosal immune system and visceral sensitivity. Aliment Pharmacol Ther. 2014 Feb;39(3):302-11. doi: 10.1111/apt.12582. Epub 2013 Dec 5.
- Yang J, Deng Y, Chu H, Cong Y, Zhao J, Pohl D, Misselwitz B, Fried M, Dai N, Fox M. Prevalence and presentation of lactose intolerance and effects on dairy product intake in healthy subjects and patients with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2013 Mar;11(3):262-268.e1. doi: 10.1016/j.cgh.2012.11.034. Epub 2012 Dec 13.
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 120100047
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Irritable Bowel Syndrome
-
ProgenaBiomeWithdrawnIrritable Bowel Syndrome | Irritable Bowel Syndrome With Diarrhea | Irritable Bowel Syndrome With Constipation | Irritable Bowel Syndrome Characterized by Constipation | Irritable Bowel Syndrome Mixed | Irritable Bowel Syndrome Without Diarrhea | Irritable Bowel | Irritable Bowel Syndrome Aggravated and other conditionsUnited States
-
Universidad Autonoma de Nuevo LeonUniversidad Autonoma de Nuevo LeonEnrolling by invitationIrritable Bowel Syndrome | Irritable Bowel Syndrome With Diarrhea | Irritable Bowel Syndrome With Constipation | Irritable Bowel Syndrome MixedMexico
-
Istanbul Medipol University HospitalTepecik Training and Research Hospital; Bozyaka Training and Research Hospital and other collaboratorsRecruitingIrritable Bowel Syndrome | Irritable Bowel Syndrome With Diarrhea | Irritable Bowel Syndrome With Constipation | Irritable Bowel Syndrome MixedTurkey
-
Research and Practical Clinical Center for Diagnostics...I.M. Sechenov First Moscow State Medical UniversityEnrolling by invitationIrritable Bowel Syndrome | Irritable Bowel Syndrome - Constipation | Irritable Bowel Syndrome - Diarrhoea | Irritable Bowel Syndrome - MixedRussian Federation
-
ClasadoCR2O B.V.CompletedIrritable Bowel Syndrome | Irritable Bowel Syndrome - Constipation | Irritable Bowel Syndrome - Diarrhoea | Irritable Bowel Syndrome - MixedBelgium, Netherlands, United Kingdom
-
Federal Stare Budgetary Scientific Institution,...I.M. Sechenov First Moscow State Medical University; RML INVEST, Torkhovsky...CompletedIrritable Bowel Syndrome | Irritable Bowel Syndrome With Diarrhea | Irritable Bowel Syndrome With Constipation | Irritable Bowel Syndrome MixedRussian Federation
-
Md Mehedi ShahriarNot yet recruitingChronic Idiopathic Constipation | Chronic Constipation | CIC | Constipation Predominant Irritable Bowel Syndrome | Irritable Bowel Syndrome (IBS-C)Bangladesh
-
Dr Anthony HobsonCompletedIrritable Bowel Syndrome (IBS) | Irritable Bowel Syndrome With Diarrhea (IBS-D)United Kingdom
-
Iuliu Hatieganu University of Medicine and PharmacyNot yet recruitingIrritable Bowel Syndrome (IBS)Romania
-
Devintec SaglRecruitingIrritable Bowel Syndrome (IBS) | Irritable Bowel Syndrome of Diarrhea Type (IBS-D)Italy, Spain, France, Belgium
Clinical Trials on dietary restriction
-
Sulaiman AlRajhi CollegesUnknownHypertension, Essential | β-hydroxybutyrate
-
University of Illinois at Urbana-ChampaignRenal Research InstituteRecruitingKidney Failure, Chronic | Dietary ModificationUnited States
-
Oslo University HospitalCompletedObesity | Dietary Modification | CVDNorway
-
Jesper Norgaard BechCompletedObstructive Sleep Apnea of Adult | Nocturnal Blood Pressure | Sodium ImbalanceDenmark
-
University of LeedsCompletedAppetitive BehaviorUnited Kingdom
-
University of DelawareCompleted
-
Maastricht University Medical CenterJessa HospitalRecruiting
-
The University of Western AustraliaCompletedObesity | Insulin Resistance | DyslipidemiaAustralia
-
Aiyoudong Children and Youth Sports Health Research...Completed
-
Shanghai Jiao Tong University School of MedicineActive, not recruiting